News
-
-
PRESS RELEASE
Tocvan Releases Next Batch of Drill Results. Infill Drilling Intersects Multiple Mineralized Zones. Exploration Drilling Hits Broad Anomalous Mineralization, Expanding Strike Potential
Tocvan Ventures Corp. releases drill results from 2024 RC drill program at Pilar Gold-Silver project in Sonora, Mexico. Highlights include extensive mineralization expansions and exploration success along the Main Zone and 4-T Trend -
-
-
-
PRESS RELEASE
Tocvan Drills Another Successful Hole Outside of Main Zone Returns High-Grade 10.9 g/t Gold over 3.1 meters, within 42.7 meters of 1.0 g/t Gold Near Surface
Tocvan Ventures Corp. announces drill results from its 2024 RC drill program at Pilar Gold-Silver project in Sonora, Mexico, revealing significant resource potential and high-grade mineralization -
-
-
-
-
University of York Chooses Alces Flight to Boost Sustainable Research
-
Alset Capital Inc. Announces AI GPU Contract with a $91.7M Option Signed by Investee Company Cedarcross
-
Ivanhoe Electric Clarifies Certain Misleading Media Headlines Regarding Its Recent Registration Statement Filing
-
FE Battery Metals Announces Positive Laboratory Results Producing Lithium Carbonate Grades Exceeding 99% Purity
-
SouthGobi Announces Update on Mongolia Tax Audit
-
Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
-
MGI – Media and Games Invest SE held its Annual General Meeting
-
Mililk® now available at Penny
-
TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
-
German Software Company comforte AG Receives International Award: Excellence in Cybersecurity for Banks and Payment Service Providers
-
Moody’s reaffirms « A1 » Outlook Stable rating of CNP Assurances SA
-
EURAZEO OPENS AN OFFICE IN TOKYO, FURTHER EXTENDING ITS INTERNATIONAL REACH
-
imerys-12-06-2024-implementation-of-the-share-buyback-program
-
COGELEC : Statement on the total number of shares and voting rights.
-
Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens